HIGHLIGHTS
- who: Ayse Seda Yazgili and collaborators from the , Munich, Germany Institute of Experimental Medicine, Christian-Albrechts University Kiel, Kiel, Germany have published the article: The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease, in the Journal: Biomolecules 2022, 12, 1150. of /2022/
- what: 11 of 14
- how: Their results showed that to maintain the therapeutic function of MSCs in myocardial infarction the acute degradation of YAP1 in the nucleus by PA200 is necessary. In this study and signaling pathway that is constitutively triggered in many different types of cancersGe . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.